Your browser doesn't support javascript.
loading
Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
Chen, Yun-Wen; Guo, Tianhuan; Shen, Lijun; Wong, Kai-Yau; Tao, Qian; Choi, William W L; Au-Yeung, Rex K H; Chan, Yuen-Piu; Wong, Michelle L Y; Tang, Johnny C O; Liu, Wei-Ping; Li, Gan-Di; Shimizu, Norio; Loong, Florence; Tse, Eric; Kwong, Yok-Lam; Srivastava, Gopesh.
Afiliação
  • Chen YW; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Guo T; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Shen L; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Wong KY; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Tao Q; Cancer Epigenetics Laboratory, Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong;
  • Choi WW; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Au-Yeung RK; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Chan YP; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Wong ML; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Tang JC; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong;
  • Liu WP; Department of Pathology, West-China Hospital of Sichuan University, Chengdu, Sichuan, China;
  • Li GD; Department of Pathology, West-China Hospital of Sichuan University, Chengdu, Sichuan, China;
  • Shimizu N; Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; and.
  • Loong F; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
  • Tse E; Division of Hematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Kwong YL; Division of Hematology, Medical Oncology and Bone Marrow Transplantation, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
  • Srivastava G; Lymphoma Research Laboratory, Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong;
Blood ; 125(10): 1589-600, 2015 Mar 05.
Article em En | MEDLINE | ID: mdl-25612622

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Nasais / Proteínas Supressoras de Tumor / Fator de Transcrição STAT3 / Linfoma Extranodal de Células T-NK / Proteínas Tirosina Fosfatases Classe 2 Semelhantes a Receptores Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Nasais / Proteínas Supressoras de Tumor / Fator de Transcrição STAT3 / Linfoma Extranodal de Células T-NK / Proteínas Tirosina Fosfatases Classe 2 Semelhantes a Receptores Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article